Maxcyte (MXCT) Other Gross PP&E Adjustments (2019 - 2026)
Maxcyte (MXCT) reported Other Gross PP&E Adjustments of -$5.2 million for Q1 2026, down 347.1% year-over-year from $2.1 million in Q1 2025, and up 35.11% on a QoQ basis from -$8.0 million in Q4 2025.
Maxcyte (MXCT) has 8 years of Other Gross PP&E Adjustments data on file, last reported at -$5.2 million in Q1 2026.
- Quarterly Other Gross PP&E Adjustments fell 347.1% year-over-year to -$5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.2 million (down 347.1% YoY) and the FY2025 annual result came in at -$8.0 million, up 58.43% from the prior year.
- Other Gross PP&E Adjustments climbed to -$5.2 million in Q1 2026 per MXCT's latest filing, from -$8.0 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $3.8 million in Q3 2024 and bottomed at -$19.3 million in Q4 2024.
- The 5-year median for Other Gross PP&E Adjustments is -$6.0 million (2023), against an average of -$3.7 million.
- The widest annual swing landed in 2022, when Other Gross PP&E Adjustments jumped 399.59%; it then slumped 347.1% in 2026.
- Tracing MXCT's Other Gross PP&E Adjustments over 5 years: stood at -$6.0 million in 2022, then tumbled by 35.5% to -$8.1 million in 2023, then slumped by 137.89% to -$19.3 million in 2024, then surged by 58.43% to -$8.0 million in 2025, then soared by 35.11% to -$5.2 million in 2026.
- Per Business Quant, the three latest MXCT Other Gross PP&E Adjustments figures stand at -$5.2 million (Q1 2026), -$8.0 million (Q4 2025), and $3.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 23.14 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -405.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -547.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -99.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.55 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.39 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 5.30 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 991.00 Mn |
| 10 | Maxcyte | 129.85 Mn | 129.85 Mn | 8.08 Mn | -5.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.20 Mn |
| Mar 31, 2026 | -5.20 Mn |
| Dec 31, 2025 | -8.02 Mn |
| Dec 31, 2025 | -8.02 Mn |
| Sep 30, 2025 | 3.65 Mn |
| Sep 30, 2025 | 3.65 Mn |
| Jun 30, 2025 | -6.71 Mn |
| Jun 30, 2025 | -6.71 Mn |
| Mar 31, 2025 | 2.11 Mn |
| Mar 31, 2025 | 2.11 Mn |
| Dec 31, 2024 | -19.30 Mn |
| Dec 31, 2024 | -19.30 Mn |
| Sep 30, 2024 | 3.84 Mn |
| Sep 30, 2024 | 3.84 Mn |
| Jun 30, 2024 | 3.72 Mn |
| Jun 30, 2024 | 3.72 Mn |
| Mar 31, 2024 | -6.89 Mn |
| Mar 31, 2024 | -6.89 Mn |
| Dec 31, 2023 | -8.11 Mn |
| Dec 31, 2023 | -8.11 Mn |
| Sep 30, 2023 | 2.58 Mn |
| Sep 30, 2023 | 2.58 Mn |
| Jun 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | 2.15 Mn |
| Mar 31, 2023 | -5.96 Mn |
| Mar 31, 2023 | -5.96 Mn |
| Dec 31, 2022 | -5.99 Mn |
| Dec 31, 2022 | -5.99 Mn |
| Sep 30, 2022 | -7.10 Mn |
| Sep 30, 2022 | -7.10 Mn |
| Jun 30, 2022 | 580,300.00 |
| Jun 30, 2022 | 580,300.00 |
| Mar 31, 2022 | -7.68 Mn |
| Mar 31, 2022 | -7.68 Mn |
| Dec 31, 2021 | -5.66 Mn |
| Dec 31, 2021 | -5.66 Mn |
| Sep 30, 2021 | 3.34 Mn |
| Sep 30, 2021 | 3.34 Mn |
| Jun 30, 2021 | -193,700.00 |
| Jun 30, 2021 | -193,700.00 |
| Dec 31, 2020 | -456,300.00 |
| Dec 31, 2020 | -456,300.00 |
| Dec 31, 2019 | -1.15 Mn |
| Dec 31, 2019 | -1.15 Mn |